Venus Medtech Stock Today
| VMTHF Stock | USD 0.27 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressSmall
|
Venus Medtech is trading at 0.27 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.27. Venus Medtech has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of November 2025 and ending today, the 26th of December 2025. Click here to learn more.
Venus Medtech Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company was founded in 2009 and is headquartered in Hangzhou, the Peoples Republic of China. Venus Medtech operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 441.01 M outstanding shares. More on Venus Medtech
Moving together with Venus Pink Sheet
Moving against Venus Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Venus Pink Sheet Highlights
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Venus Medtech [VMTHF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 855.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Venus Medtech's market, we take the total number of its shares issued and multiply it by Venus Medtech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Venus Medtech classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 441.01 M outstanding shares.
Venus Medtech has accumulated about 2.96 B in cash with (456.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.75, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Venus Medtech Probability Of Bankruptcy
Ownership AllocationVenus Medtech shows a total of 441.01 Million outstanding shares. Venus Medtech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Venus Ownership Details
Venus Medtech Risk Profiles
| Mean Deviation | 2.03 | |||
| Standard Deviation | 5.53 | |||
| Variance | 30.54 | |||
| Risk Adjusted Performance | (0.09) |
Venus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Venus Medtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Venus Medtech Corporate Management
| Shakeel Osman | VP Europe | Profile | |
| Haiyue Ma | CFO Sec | Profile | |
| Joyce Heo | Director Sales | Profile | |
| Zhenjun Zi | GM Founder | Profile | |
| HouSen MEng | CTO COO | Profile | |
| Christopher Richardson | Head Operations | Profile | |
| Min Zeng | Ex Chairman | Profile |
Other Information on Investing in Venus Pink Sheet
Venus Medtech financial ratios help investors to determine whether Venus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Venus with respect to the benefits of owning Venus Medtech security.